YL

Yan Lou

NT Nikang Therapeutics: 4 patents #1 of 3Top 35%
NP Newave Pharmaceutical: 2 patents #2 of 2Top 100%
PB Principia Biopharma: 1 patents #1 of 6Top 20%
📍 Pleasanton, CA: #23 of 617 inventorsTop 4%
🗺 California: #2,139 of 65,961 inventorsTop 4%
Overall (2022): #14,256 of 548,613Top 3%
7
Patents 2022

Issued Patents 2022

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
11518772 Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors Jiping Fu, Yigang He 2022-12-06
11459340 Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors Jiping Fu, Yigang He 2022-10-04
11420936 Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases Jiping Fu, Yigang He 2022-08-23
11365206 BCL-2 inhibitors Yi-Cheng Chen 2022-06-21
11279711 Condensed heterocyclic derivates as BCL-2 inhibitors for the treatment of neoplastic diseases Yi-Cheng Chen 2022-03-22
11267782 Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2α inhibitors Jiping Fu, Yigang He 2022-03-08
11225493 Immunoproteasome inhibitors Timothy D. Owens, Kenneth Albert Brameld, David Michael Goldstein 2022-01-18